All In Biotech

Drug Trial Radar · NCT01965158

Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy

Last checked: Nov 20, 2026Latest source record: May 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 547 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

547

Actual

Start

Aug 29, 2013

Primary completion

Jan 22, 2015

Study completion Jan 22, 2015

Sponsor

Lead sponsor
ShionogiIndustry
Sponsor type
Industry
First posted
Oct 18, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of naldemedine in the treatment of opioid-induced constipation (OIC) in adults with non-malignant chronic pain who are not using laxatives.

Conditions

  • Opioid-induced Constipation

Interventions

  • NaldemedineDrug

    Naldemedine 0.2 mg tablet taken orally once a day

  • PlaceboDrug

    Placebo tablet taken orally once a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With a Spontaneous Bowel Movement (SBM) ResponseTime frame: 12-week treatment period

Locations

65 sites in 7 countries. Site status is shown where the registry gives one.

  • Shionogi Research Site

    Birmingham, Alabama

  • Shionogi Research Site

    Phoenix, Arizona

  • Shionogi Research Site

    Fresno, California

  • Shionogi Research Site

    Long Beach, California

  • Shionogi Research Site

    National City, California

  • Shionogi Research Site

    North Hollywood, California

  • Shionogi Research Site

    Oceanside, California

  • Shionogi Research Site

    Golden, Colorado

  • Shionogi Research Site

    Miami, Florida

  • Shionogi Research Site

    Miami Springs, Florida

  • Shionogi Research Site

    Orlando, Florida

  • Shionogi Research Site

    Sarasota, Florida

  • Shionogi Research Site

    West Palm Beach, Florida

  • Shionogi Research Site

    Winter Park, Florida

  • Shionogi Research Site

    Marietta, Georgia

  • Shionogi Research Site

    Shreveport, Louisiana

  • Shionogi Research Site

    Caro, Michigan

  • Shionogi Research Site

    Flint, Michigan

  • Shionogi Research Site

    Hazelwood, Missouri

  • Shionogi Research Site

    Las Vegas, Nevada

  • Shionogi Research Site

    Belvidere, New Jersey

  • Shionogi Research Site

    East Brunswick, New Jersey

  • Shionogi Research Site

    Albuquerque, New Mexico

  • Shionogi Research Site

    Great Neck, New York

  • Shionogi Research Site

    Hollis, New York

  • Shionogi Research Site

    New Windsor, New York

  • Shionogi Research Site

    Winston-Salem, North Carolina

  • Shionogi Research Site

    Cincinnati, Ohio

  • Shionogi Research Site

    Oklahoma City, Oklahoma

  • Shionogi Research Site

    Medford, Oregon

  • Shionogi Research Site

    West Reading, Pennsylvania

  • Shionogi Research Site

    Chattanooga, Tennessee

  • Shionogi Research Site

    Arlington, Texas

  • Shionogi Research Site

    Austin, Texas

  • Shionogi Research Site

    Dallas, Texas

  • Shionogi Research Site

    Houston, Texas

  • Shionogi Research Site

    San Antonio, Texas

  • Shionogi Research Site

    Sankt Pölten, Austria

  • Shionogi Research Site

    Vienna, Austria

  • Shionogi Research Site

    Hradec Králové, Czechia

Showing 40 of 65 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.